new_0222_0493|RPHM|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0493|RPHM|Long Name|1|1|Reneo Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Reneo Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Reneo Pharmaceuticals Inc Inventories (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Reneo Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Reneo Pharmaceuticals Inc Book Value (Quarterly) (USD)|Reneo Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Reneo Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc EV to Revenues|Reneo Pharmaceuticals Inc EV to Earnings|Reneo Pharmaceuticals Inc EV to Free Cash Flow|Reneo Pharmaceuticals Inc EV to Assets (Quarterly)|Reneo Pharmaceuticals Inc PS Ratio|Reneo Pharmaceuticals Inc PE Ratio|Reneo Pharmaceuticals Inc Price to Book Value|Reneo Pharmaceuticals Inc PEG Ratio|Reneo Pharmaceuticals Inc Debt to Equity Ratio|Reneo Pharmaceuticals Inc Dividend Yield|Reneo Pharmaceuticals Inc Shareholder Yield (TTM)|Reneo Pharmaceuticals Inc Percent of Shares Outstanding Short|Reneo Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc Return on Invested Capital|Reneo Pharmaceuticals Inc Quality Ratio Score|Reneo Pharmaceuticals Inc Momentum Score|Reneo Pharmaceuticals Inc Beta (1Y)|Reneo Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Reneo Pharmaceuticals Inc Institutional Investor Ownership Percentage|Reneo Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Reneo Pharmaceuticals Inc Total Employees (Annual)|Reneo Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Reneo Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Shares Outstanding|Reneo Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Reneo Pharmaceuticals Inc Payout Ratio|Reneo Pharmaceuticals Inc Quick Ratio (Quarterly)|Reneo Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Reneo Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Reneo Pharmaceuticals Inc Effective Tax Rate (TTM)|Reneo Pharmaceuticals Inc Return on Equity|Reneo Pharmaceuticals Inc Net Income (TTM) (USD)|Reneo Pharmaceuticals Inc Revenue (TTM) (USD)|Reneo Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Reneo Pharmaceuticals Inc Revenue (Quarterly) (USD)|Reneo Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Reneo Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Price (USD)|Reneo Pharmaceuticals Inc Total Return Price (USD)|Reneo Pharmaceuticals Inc Enterprise Value (USD)|Reneo Pharmaceuticals Inc 30-Day Average Daily Volume|Reneo Pharmaceuticals Inc 1 Year Price Returns (Daily)|Reneo Pharmaceuticals Inc Short Interest|Reneo Pharmaceuticals Inc PE Ratio (Forward)|Reneo Pharmaceuticals Inc PE Ratio (Forward 1y)|Reneo Pharmaceuticals Inc PS Ratio (Forward)|Reneo Pharmaceuticals Inc PS Ratio (Forward 1y)|Reneo Pharmaceuticals Inc Quarterly EPS Estimates (USD)|Reneo Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|Reneo Pharmaceuticals Inc Quarterly EPS Surprise|Reneo Pharmaceuticals Inc Quarterly Revenue Surprise|Reneo Pharmaceuticals Inc Quarterly Actual EPS (USD)|Reneo Pharmaceuticals Inc Quarterly Actual Revenue (USD)|Reneo Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Reneo Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Reneo Pharmaceuticals Inc Price Target (USD)|Reneo Pharmaceuticals Inc Consensus Recommendation|Reneo Pharmaceuticals Inc Price Target Num Estimates|Reneo Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Reneo Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Reneo Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|Reneo Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|Reneo Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|Reneo Pharmaceuticals Inc Other Properties (Quarterly) (USD)|Reneo Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0493|RPHM|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0493|RPHM||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0493|RPHM||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.43835616438|0|0|0|1.43827160494|0|0|1.43835616438|0|15.3157894737|0|91|91|0|0|0|0|0|30.6666666667|91.3333333333|91|91.3333333333|91.3333333333|31.1428571429|0|91|0|0|91.3333333333|91.4|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|1.43835616438|1.43835616438|1.43835616438|1.44210526316|0|15.3157894737|0|0|0|0|91.4285714286|91.4285714286|91.5|0|91.5|91.5|29.7777777778|33.5|31.4444444444|20.2142857143|31.4444444444|24.3636363636|29.7777777778|91.3333333333|91.3333333333|0|0|0|0|91
new_0222_0493|RPHM||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|219|0|0|0|162|0|0|219|0|19|0|3|3|0|0|0|0|0|9|6|3|6|6|7|0|3|0|0|6|5|0|0|3|0|0|0|0|6|6|6|219|219|219|190|0|19|0|0|0|0|7|7|2|0|2|2|9|8|9|14|9|11|9|6|6|0|0|0|0|3
new_0222_0493|RPHM||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0493|RPHM|202003|202003|202003||||||||||||||||||||||||||||||||||7.7883||-0.5689|0.924||||||-0.5689|||||||||-4.431|-4.431|0.071||||||||||||||||||||||||3.578|0.009|||||
new_0222_0493|RPHM|202006|202006|202006||||||||||||||||||||||||||||||||||7.7883||-0.4734|0.882||||||-0.4734|0||||||||-3.687|-3.687|0.012||||||||||||||||||||||||2.817|0.009|||||
new_0222_0493|RPHM|202009|202009|202009||||||||||||||||||||||||||||||||||7.7883||-0.6541|0.668||||||-0.6541|0||||||||-5.094|-5.094|0.005||||||||||||||||||||||||4.431|0.009|||||
new_0222_0493|RPHM|202012|202012|202012|55.025|53.613||0.069||97.336|4.58|92.756||-42.115|-44.958|||||||||||||||0.908|0|||||||24.2107|23|-0.2583|1.133|||24.2107|||-0.2583||||-19.465|||||-6.253|-6.253|-0.002||||||||||||||||||||||||5.118|0.01|||||0.122
new_0222_0493|RPHM|202103|202103|202103|93.56|91.221||0.081||144.038|3.93|140.108||-48.717|-52.17|||||||||||||||0.556|0|||||||24.2107|29|-0.2979|1.742|||24.2107|||-0.2979||||-22.246|||||-7.212|-7.212|0.002|||||||||||-0.42|0|-728.5714||-3.48|0||||||||5.472|0.01|||||0.144
new_0222_0493|RPHM|202104|202103|202103|||||||||||||||-11.3268|||||||0||1.0356|||||||||25.1632|||||24.2107|||||||||||||||||14.4|14.4|257.4131|||250715||||||||||||||||||||||||
new_0222_0493|RPHM|202105|202103|202103|||||||||||||||-6.7261|||||||0||2.8625|||||||||25.0816|||||24.2863|||||||||||||||||10.05|10.05|152.8563|73164.0667||695206|||||||||||0|0|31.3333|1.3333|3|-2.9433|-2.4667|||||||
new_0222_0493|RPHM|202106|202106|202106|171.141|167.331||0.085||3.753|3.336|0.417||167.551|-61.386||||-2.0099||||1.3525|||0||4.8179||0.434|0.003||||||95.0652|21.3644|29|-0.43|2.949|24.2887||24.2887|||-0.43|-84.639|||-27.775|||||-9.216|-9.216|0.012|9.33|9.33|59.2826|92288.9||1170210|||||-0.3767|0|-14.1583||-0.43|0||||1.3333||||6.279|0.01|||||0.158
new_0222_0493|RPHM|202107|202106|202106|||||||||||||||-1.0711||||1.1872|||0||4.7979|||||||||95.8405||||||||||||||||||||||8.19|8.19|31.5935|69341.4667||1165355||||||||||||||1.3333||||||||||
new_0222_0493|RPHM|202108|202106|202106|||||||||||||||-3.4864||||1.6124|||0||4.6132|||||||||95.1587|||||24.4053|||||||||||||||||11.07|11.07|102.8357|77046.2667||1125857|||||||||||0|0|31.3333|1.3333|3|-3.21|-3.0067|||||||
new_0222_0493|RPHM|202109|202109|202109|162.665|157.734||0.2||6.735|6.353|0.382||156.208|-74.121||||-0.7196||||1.1641|||0||4.7767||1.271|0.003||||||95.4497|24.3968|34|-0.52|3.434|24.4077||24.4077|||-0.52|-0.002|||-35.416|||||-12.735|-12.735|0.017|7.45|7.45|24.1034|122068.7667||1165885|||||-0.42|0|-23.8095||-0.52|0||||||||9.318|0.013|||||0.286
new_0222_0493|RPHM|202110|202109|202109|||||||||||||||-0.0711||||1.025|||0||1.1508|||||||||95.5179||||||||||||||||||||||6.56|6.56|2.3805|28821.9667||280872|||||||||||0|0|31.3333|1.3333|3|-3.21|-3.0067|||||||
new_0222_0493|RPHM|202111|202109|202109|||||||||||||||-0.3076||||1.0757|||0||1.1374|||||||||95.3211|||||24.4239|||||||||||||||||6.88|6.88|10.3024|29907.6||277801|||||||||||0|0|34.75|1.25|4|-3.2633|-3.0867|||||||
new_0222_0493|RPHM|202112|202112|202112|||||||||||||||-1.5252||||1.3368|||0||1.019|||||||||95.1114||||||||||||||||||||||8.55|8.55|51.0903|72926.6||248870|||||-0.574|0|||||0|0|33.4|1.4|5|-3.41|-2.98|||||||
new_0222_0493|RPHM|202201|202112|202112|||||||||||||||0.181||||0.971|||0||0.6973|||||||||83.9224||||||||||||||||||||||6.21|6.21|-6.0616|58587.6333||170307|||||||||||0|0|32.5|1.3333|6|-2.838|-2.74|||||||
new_0222_0493|RPHM|202202|202112|202112|||||||||||||||1.0778||||0.7786|||0|||||||||||||||||||||||||||||||||4.98|4.98|-36.103|42575.8333|||||||||||||||32.5|1.3333|6|||||||||
new_0222_0493|RPHM|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.62|0||||||||||||||||||
new_0222_0493|RPHM|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.686|0||||||||||||||||||
new_0222_0493|RPHM|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.728|0||||||||||||||||||
new_0222_0493|RPHM|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.814|0||||||||||||||||||